Combination Therapy of Bone Marrow Mesenchymal Stromal Cells and Azathioprine Not Affect the Clinical Course Luminal Crohn's Disease

被引：0
|
作者：
Knyazev, Oleg [1 ]
Kagramanova, Anna [1 ]
Fadeeva, Nina [1 ]
机构：
[1] Moscow Clin Res Ctr, Moscow, Russia
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-123
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [41] Bone marrow mesenchymal stromal cells for diabetes therapy: touch, fuse, and fix?
    Zahra Azizi
    Roya Abbaszadeh
    Roxana Sahebnasagh
    Amir Norouzy
    Elahe Motevaseli
    Kathrin Maedler
    Stem Cell Research & Therapy, 13
  • [42] Clinical Trial to Explore Therapeutic Potential of Bone Marrow Cells for Crohn's Disease
    Printz, Carrie
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2014, 7 (03): : 185 - 185
  • [43] Phenotypical and Functional Characterization of in Vitro Expanded Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Crohn's Disease.
    Bernardo, Marja Ester
    Avanzini, Maria Antonietta
    Ciccocioppo, Rachele
    Perotti, Cesare
    Cometa, Angela Maria
    Moretta, Antonia
    Valli, Monica
    Novara, Francesca
    Maccario, Rita
    Corazza, Gino Roberto
    Locatelli, Franco
    BLOOD, 2008, 112 (11) : 888 - 888
  • [44] Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease
    Molendijk, Ilse
    van der Meulen-de Jong, Andrea E.
    Verspaget, Hein W.
    Veenendaal, Roeland A.
    Hommes, Daniel W.
    Bonsing, Bert A.
    Peeters, Koen C. M. J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (10) : 1148 - 1154
  • [45] Dependence of the Duration of Clinical Remission in Crohn's Disease From the Frequency of Introduction of Mesenchymal Stromal Cells
    Rogerio, Parra
    Julio, Chebli
    Liliana, Chebli
    Sergio, Lima Junior
    Manoel, Neto
    Terry, Medeiros
    Francesca, Faria
    Marley, Feitosa
    Omar, Feres
    Joaquim, Rocha Jose
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S2 - S2
  • [46] Apoptosis in mesenchymal stromal cells activates an immunosuppressive secretome predicting clinical response in Crohn's disease
    Cheung, Tik Shing
    Giacomini, Chiara
    Cereda, Matteo
    Avivar-Valderas, Alvaro
    Capece, Daria
    Bertolino, Giuliana Minani
    Delarosa, Olga
    Hicks, Ryan
    Ciccocioppo, Rachele
    Franzoso, Guido
    Galleu, Antonio
    Ciccarelli, Francesca D.
    Dazzi, Francesco
    MOLECULAR THERAPY, 2023, 31 (12) : 3531 - 3544
  • [47] SAFETY AND EFFICACY OF AUTOLOGOUS AND METABOLICALLY FIT BONE MARROW MESENCHYMAL STROMAL CELLS (BM-MSC) IN MEDICALLY REFRACTORY CROHN'S DISEASE (CD)
    Dhere, T.
    Copland, I.
    Chiang, K.
    Garcia, M.
    Chinnadurai, R.
    Chikkabbagilu, M.
    Galipeau, J.
    Kugathasan, S.
    CYTOTHERAPY, 2016, 18 (06) : S12 - S12
  • [48] The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses
    Dhere, T.
    Copland, I.
    Garcia, M.
    Chiang, K. Y.
    Chinnadurai, R.
    Prasad, M.
    Galipeau, J.
    Kugathasan, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (05) : 471 - 481
  • [49] The Use of Bone Marrow Stromal Cells (Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells) for Alveolar Bone Tissue Engineering: Basic Science to Clinical Translation
    Kagami, Hideaki
    Agata, Hideki
    Inoue, Minoru
    Asahina, Izumi
    Tojo, Arinobu
    Yamashita, Naohide
    Imai, Kohzoh
    TISSUE ENGINEERING PART B-REVIEWS, 2014, 20 (03) : 229 - 232
  • [50] USE OF AUTOLOGOUS BONE MARROW MESENCHYMAL STROMAL CELLS FOR CARTILAGE REPAIR CLINICAL TRIALS
    Law, P.
    Wong, L.
    Wong, F.
    Tan, S.
    Liew, Y.
    Vattipalli, R.
    Lee, E.
    Hui, J. H.
    CYTOTHERAPY, 2013, 15 (04) : S45 - S45
12345